Cargando…
Single center experience with subcutaneous ICD in combination with previously implanted endocardial or epicardial antibradycardia or cardiac resynchronization devices
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Subcutaneous ICD (S-ICD) is an established therapy for prevention of sudden cardiac death due to ventricular arrhythmias (VA). One major drawback of the S-ICD is the lack of antibradycardia pacing. Theroretically the S-ICD can be u...
Autores principales: | Som, Z, Nagy, Z, Kassa, K I, Mladoniczky, S, Kardos, A, Foldesi, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207488/ http://dx.doi.org/10.1093/europace/euad122.432 |
Ejemplares similares
-
Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up
por: De Veld, J A, et al.
Publicado: (2023) -
A tertiary centre experience of routine exercise testing as part of subcutaneous ICD vector mapping
por: Hall, P, et al.
Publicado: (2023) -
A 25-year single-center experience with transvenous and subcutaneous ICD patients under thirty years of age
por: Lewandowski, M, et al.
Publicado: (2023) -
A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation
por: Lopez Perales, C, et al.
Publicado: (2023) -
ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
por: Kleemann, T, et al.
Publicado: (2023)